HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.

Abstract
A hallmark of systemic lupus erythematosus (SLE) is the breaking of B-cell tolerance with the generation of high-affinity autoantibodies; however, the antibody-independent features of the B-cell compartment in SLE are less understood. In this study, we performed an extensive examination of B-cell subsets and their proinflammatory properties in a Chinese cohort of new-onset SLE patients. We observed that SLE patients exhibited an increased frequency of transitional B cells compared with healthy donors and rheumatoid arthritis patients. Plasma from SLE patients potently promoted the survival of transitional B cells in a type I IFN-dependent manner, which can be recapitulated by direct IFN-α treatment. Furthermore, the effect of IFN-α on enhanced survival of transitional B cells was associated with NF-κB pathway activation and reduced expression of the pro-apoptotic molecule Bax. Transitional B cells from SLE patients harbored a higher capacity to produce proinflammatory cytokine IL-6, which was also linked to the overactivated type I IFN pathway. In addition, the frequency of IL-6-producing transitional B cells was positively correlated with disease activity in SLE patients, and these cells were significantly reduced after short-term standard therapies. Thus, the current study provides a direct link between type I IFN pathway overactivation and the abnormally high frequency and proinflammatory properties of transitional B cells in active SLE patients, which contributes to the understanding of the roles of type I IFNs and B cells in the pathogenesis of SLE.
AuthorsMei Liu, Qiang Guo, Chunmei Wu, Delphine Sterlin, Shyamal Goswami, Ying Zhang, Teng Li, Chunde Bao, Nan Shen, Qiong Fu, Xiaoming Zhang
JournalCellular & molecular immunology (Cell Mol Immunol) Vol. 16 Issue 4 Pg. 367-379 (04 2019) ISSN: 2042-0226 [Electronic] China
PMID29563616 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • BAX protein, human
  • Interferon-alpha
  • Interleukin-6
  • NF-kappa B
  • bcl-2-Associated X Protein
Topics
  • Adolescent
  • Adult
  • Aged
  • Apoptosis (drug effects, immunology)
  • Arthritis, Rheumatoid (blood, immunology)
  • Autoantibodies (blood)
  • B-Lymphocyte Subsets (drug effects, immunology, metabolism)
  • Cell Survival (drug effects, immunology)
  • Cells, Cultured
  • China
  • Cohort Studies
  • Female
  • Humans
  • Inflammation (immunology, metabolism)
  • Interferon-alpha (pharmacology)
  • Interleukin-6 (metabolism)
  • Leukocytes, Mononuclear (metabolism)
  • Lupus Erythematosus, Systemic (blood, immunology, physiopathology, therapy)
  • Male
  • Middle Aged
  • NF-kappa B (metabolism)
  • Signal Transduction (drug effects, immunology)
  • bcl-2-Associated X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: